Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Alzheimers Dement. 2023 Feb 23;19(8):3519–3527. doi: 10.1002/alz.12974

Table 2.

Ordinal logistic regression models of plasma PlGF as a diagnostic VCID biomarker.

Outcome
Variable
Cohort 1 (n=89) Cohort 2 (n=93) Cohort 3 (n=96) Combined Cohort (n=322)
Primary Beta OR
(CI)
p Beta OR
(CI)
p Beta OR
(CI)
p Beta OR
(CI)
p
Imaging Outcome* (Fazekas) 0.095 1.10 (0.93-1.30) 0.27 0.249 1.28 (1.06-1.55) 0.011 0.217 1.24 (1.05-1.47) 0.011 0.147 1.16 (1.07-1.25) 0.0003
Cognitive Outcome* (CDR) 0.162 1.18 (0.99-1.40) 0.068 0.231 1.26 (1.09 - 1.45) 0.001 0.463 1.59 (1.31-1.93) <0.0001 0.202 1.22 (1.14-1.32) <0.0001
Secondary
Imaging Outcome** (vWMH) 0.048 1.78e-4 0.057 2.50e-3 0.172 5.93e-5 0.104 5.42e-15
Cognitive Outcome** (UDS3-EF) −0.022 0.83 −0.052 0.147 −0.049 0.108 −0.030 0.070
*

Age- and sex-adjusted ordinal logistic regression model using unadjusted plasma PlGF values (pg/mL).

**

Age- and sex-adjusted linear regression model using unadjusted plasma PlGF values (pg/mL).

CDR – Cognitive Dementia Rating Scale; vWMH – volumetric white matter hyperintensity imaging; UDS3-EF – Uniform Data Set 3.0 – Executive Function score